Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective Study of Adherence to 4-dose vs 5-dose Rabies Vaccine (Vero Cell) Schedules
CTR20252241Phase 4Completed
- Sponsor
- Shandong Yidu Biotechnology
- Start
- Jun 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of rabies vaccine (Vero cell) in rabies, sponsored by Shandong Yidu Biotechnology. Started Jun 2025; status: completed.
02
Drugs
rabies vaccine (Vero cell)
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20252241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252241.